Tiova Rotacap
Developed to alleviate chronic obstructive pulmonary disease to support better airway function and facilitate ease of breathing.
Strengths: 15caps
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Spiriva
- Therapeutic class
Anticholinergic Bronchodilator
- Pharmacological class
LAMA
- Contraindications
hypersensitivity to tiotropium; hypersensitivity to atropine
- Minor side effects
dry mouth; pharyngitis
- Moderate side effects
constipation; blurred vision; tachycardia; urinary retention
- Dosage forms
Inhalation powder, hard capsule
- Administration route
Inhalation use
- Prescription status
POM
- Manufacturer
Cipla Ltd
- Onset Time
30–60 minutes
- Duration
24 hours
- Storage instructions
Store below 25°C in a dry place.
- Drug interactions
Anticholinergic agents
- Age restrictions
Not for use in children.
- Pregnancy and breastfeeding
Consult your physician if pregnant or breastfeeding.
Precautions and warnings
use with caution in narrow-angle glaucoma; use with caution in urinary retention; avoid contact with eyes
Serious side effects
bronchospasm — requires immediate medical attention; angioedema — requires immediate medical attention
Patient summary
Developed to alleviate chronic obstructive pulmonary disease to support better airway function and facilitate ease of breathing.
Mechanism of action
Tiotropium is a long-acting muscarinic antagonist that works by inhibiting M3 receptors on airway smooth muscles, resulting in bronchodilation to maintain open airflow.
Tiova Rotacap
Developed to alleviate chronic obstructive pulmonary disease to support better airway function and facilitate ease of breathing.
Editorial Notes
- Active ingredient(s): Tiotropium
- Listed indication(s): Chronic Obstructive Pulmonary Disease
Available option
- 1 bottle - 15 caps770-15-caps-5784